drugset / Trial / NCT05200000

Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis

NCT05200000 ↗

Phase 1 Completed 20 enrolled TBF Genie Tissulaire
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this open, non-comparative, multicenter trial is to assess the impact of eye drops made of Wharton's jelly extract in the treatment of chronic keratitis that failed available therapies.

Timeline

Start
2020-01-08
Primary completion
2023-06-20
Completion
2023-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject SygeLIX-Coll-T Unknown — Topical

Indications